Evidence supporting the use of: Resveratrol conjugates (mixed)
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol, a polyphenolic compound found in grapes, berries, and peanuts, has been investigated for its potential benefits in osteoporosis through both in vitro and animal studies. The scientific rationale is based on its antioxidant and phytoestrogenic properties, which may influence bone metabolism. Research indicates that resveratrol can stimulate osteoblast (bone-forming cell) activity and inhibit osteoclast (bone-resorbing cell) differentiation, primarily via modulation of signaling pathways such as SIRT1 and the Wnt/β-catenin pathway. Animal models of osteoporosis, particularly postmenopausal models (ovariectomized rats), have demonstrated that resveratrol supplementation can improve bone mineral density and bone microarchitecture. However, evidence in humans is limited and inconsistent. A few small clinical trials suggest potential improvements in bone turnover markers with resveratrol supplementation, but no large-scale, long-term trials have demonstrated reductions in fracture risk or clinically significant improvements in bone density. Furthermore, most studies have used pure resveratrol rather than "resveratrol conjugates (mixed)", and the effects of these mixtures are even less well studied. In summary, resveratrol and its conjugates show promise for osteoporosis prevention or adjunctive treatment based on preclinical data, but robust clinical validation in humans is lacking. The overall quality and quantity of evidence supporting its use for osteoporosis remain low at this time.

More about Resveratrol conjugates (mixed)
More about Osteoporosis

Products containing Resveratrol conjugates (mixed)

We currently have no products on Vitabase that contain this ingredient.